Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
Gilead Signs Remdesivir Licensing Agreements With Five Drugmakers
Zynga Inc. (ZNGA) Earnings Show EPS Loss of 11 Cents
BioNTech’s Potential COVID-19 Vaccine Is Already Priced In, Says JPMorgan
29/4/20: Surprising Effects of COVID19 on U.S. Labor Force
The fire in Treasurys
GDP + GFC = Fragile
COVID-19 And The Soloflex Economy
Expanding digital financial services can help developing economies cope with crisis now and boost growth later
Five Ways Philanthropists Can Support Nonprofits Through COVID-19 and Other Challenges
With Bitcoin Price Surging, What Do Key Trends Say About BTC Halving?
Report: Bitmain Earned Over $300 Million in 2020 Despite Rumored Problems
COVID-19 (coronavirus): Universal health coverage in times of crisis
Johnson & Johnson’s Brand Value Continues to Tumble
Essential Workers Virtual Panel Discussion